0001618835-19-000135.txt : 20190731 0001618835-19-000135.hdr.sgml : 20190731 20190628163703 ACCESSION NUMBER: 0001618835-19-000135 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20190628 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Evofem Biosciences, Inc. CENTRAL INDEX KEY: 0001618835 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 208527075 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 12400 HIGH BLUFF DRIVE STREET 2: SUITE 600 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 550-1900 MAIL ADDRESS: STREET 1: 12400 HIGH BLUFF DRIVE STREET 2: SUITE 600 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: Neothetics, Inc. DATE OF NAME CHANGE: 20140905 CORRESP 1 filename1.htm Document
EVOFEM BIOSCIENCES, INC.
12400 High Bluff Drive, Suite 600
San Diego, CA 92130


June 28, 2019


VIA EDGAR

United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549


Attention: Jeffrey Gabor

RE:     Evofem Biosciences, Inc.
Registration Statement on Form S-3
Filed June 24, 2019
File No. 333-232303
Request for Acceleration
    
Ladies and Gentlemen:

With respect to the above-referenced Registration Statement on Form S-3 (the “Registration Statement”), and pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, the undersigned hereby respectfully requests, on behalf of Evofem Biosciences, Inc. (the “Company”), that the Securities and Exchange Commission accelerate the effective date of the Registration Statement to Tuesday, July 2, 2019, at 4:05 p.m. Eastern Time, or as soon as practicable thereafter.

The cooperation of the staff in meeting the timetable described above is very much appreciated.

Please call Melanie Ruthrauff Levy of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Company, at (858) 314-1873, with any comments or questions regarding the Registration Statement.

Very truly yours,

EVOFEM BIOSCIENCES, INC.


/s/ Justin J. File                
Justin J. File
Chief Financial Officer


cc:    Alexander Fitzpatrick, Evofem Biosciences, Inc.
Adam C. Lenain, Esq., Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.